Pramirol SR 2.1 Tablet is a prescription medicine that is available as a Tablet. Primarily, it is used for the treatment of Parkinson's Disease. Other than this, Pramirol SR 2.1 Tablet has some other therapeutic uses, which have been discussed ahead.
The optimal dosage of Pramirol SR 2.1 Tablet is largely dependent on the individual's body weight, medical history, gender and age. Individual symptoms and route of administration also determines the right dosage. Refer to the dosage section for a detailed discussion.
Besides the aforementioned side effects, there are other adverse effects of Pramirol SR 2.1 Tablet as well, which are listed below. Such side effects of Pramirol SR 2.1 Tablet normally do not last long and go away once the treatment is completed. However, if these continue for a longer time, consult your doctor right away.
It is also important to note that Pramirol SR 2.1 Tablet has a Moderate effect for pregnant women and Severe effect on lactating mothers. In addition, Pramirol SR 2.1 Tablet's effects on the liver, heart and kidney are discussed below in the Pramirol SR 2.1 Tablet related warnings section.
Pramirol SR 2.1 Tablet is not recommended if you suffer from certain medical conditions as it can have adverse effects. Schizophrenia, Heart Disease, Kidney Disease are examples of such conditions.
Besides this, Pramirol SR 2.1 Tablet may also have severe interaction with some medicines. A complete list of these interactions is given below.
In addition to the above precautions for Pramirol SR 2.1 Tablet, it is important to know that it is not safe while driving, and is not habit-forming.
Pramirol SR 2.1 Tablet is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Pramirol SR 2.1 Tablet safe for pregnant women?
Pregnant women may experience moderate side effects from Pramirol. It is best to stop taking Pramirol immediately and inform your doctor if you notice any discomfort.
Is the use of Pramirol SR 2.1 Tablet safe during breastfeeding?
Pramirol should not be taken without taking your doctor's advice, as it may have severe side effects on breastfeeding women.
What is the effect of Pramirol SR 2.1 Tablet on the Kidneys?
Pramirol may have mild side effects on the kidneys.
What is the effect of Pramirol SR 2.1 Tablet on the Liver?
There are no any side effects of Pramirol on the liver.
What is the effect of Pramirol SR 2.1 Tablet on the Heart?
Pramirol has very mild side effects on the heart.
Pramirol SR 2.1 Tablet should not be taken with following medicines due to severe side effects it may cause to patients -
Moderate
If you are suffering from any of the following diseases, you should not take Pramirol SR 2.1 Tablet unless your doctor advises you to do so -
Is this Pramirol SR 2.1 Tablet habit forming or addictive?
Pramirol SR 2.1 Tablet is not addictive in nature.
Is it safe to drive or operate heavy machinery when consuming?
No, you should not drive or operate heavy machinery after taking Pramirol SR 2.1 Tablet as you may feel sleepy.
Is it safe?
Yes, but take Pramirol SR 2.1 Tablet only as per medical advice.
Is it able to treat mental disorders?
Pramirol SR 2.1 Tablet has been seen to have positive effect on patients with mental disorders.
Interaction between Food and Pramirol SR 2.1 Tablet
Eating certain foods may increase the time it takes Pramirol SR 2.1 Tablet to have an effect. You should consult your doctor about it.
Interaction between Alcohol and Pramirol SR 2.1 Tablet
Taking alcohol with Pramirol SR 2.1 Tablet can be dangerous.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Mirapex® (pramipexole dihydrochloride)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1043-1044
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 430-431